/MKEAF
MKEAF Stock - Mauna Kea Technologies S.A.
Healthcare|Medical - DevicesOTC
$0.37+0.00%
+$0.00 (+0.00%) • Jun 11
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.78
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.41
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MKEAF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.37 – $0.37
TARGET (TP)$0.43
STOP LOSS$0.34
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.05
52W High$0.37
52W Low$0.37
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.66M | $11.03M | $7.48M | $7.70M | $6.53M |
| Gross Profit | $6.44M | $8.91M | $5.47M | $5.71M | $4.38M |
| Gross Margin | 84.1% | 80.8% | 73.2% | 74.2% | 67.1% |
| Operating Income | $-6,049,000 | $1.23M | $-8,983,000 | $-12,218,000 | $-18,816,000 |
| Net Income | $-10,404,000 | $-3,727,000 | $-11,180,000 | $-13,445,000 | $-12,791,000 |
| Net Margin | -135.9% | -33.8% | -149.5% | -174.6% | -196.0% |
| EPS | $-0.15 | $-0.07 | $-0.25 | $-0.35 | $-0.42 |
Company Overview
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MKEAFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.08
Q2 2025
EPS Surprise History
Q1 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q4 24
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q4 2025 | Oct 2, 2025 | — | — | — | — |
Q2 2025 | Apr 24, 2025 | — | $-0.08 | — | — |
Q4 2024 | Oct 15, 2024 | — | $-0.09 | — | — |
Q2 2024 | Apr 25, 2024 | — | $-0.12 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.06 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.06 | — | — |
Q4 2022 | Oct 27, 2022 | — | — | — | — |
Q2 2022 | Apr 21, 2022 | — | $-0.15 | — | — |
Q4 2021 | Oct 28, 2021 | — | $-0.15 | — | — |
Q1 2021 | Jan 21, 2021 | — | $-0.18 | — | — |
Q4 2020 | Oct 19, 2020 | — | $-0.18 | — | — |
Q2 2020 | Apr 28, 2020 | — | $-0.25 | — | — |
Q4 2019 | Oct 17, 2019 | — | $-0.25 | — | — |
Q1 2019 | Mar 20, 2019 | — | — | — | — |
Q4 2018 | Oct 18, 2018 | — | — | — | — |
Q2 2018 | Apr 25, 2018 | — | — | — | — |
Q4 2017 | Oct 19, 2017 | — | — | — | — |
Q1 2017 | Mar 23, 2017 | — | — | — | — |
Q4 2016 | Nov 2, 2016 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about MKEAF
What is MKEAF's current stock price?
Mauna Kea Technologies S.A. (MKEAF) is currently trading at $0.37 per share. The stock has moved +0.00% today.
What is the analyst price target for MKEAF?
No analyst price targets are currently available for this stock.
What sector is Mauna Kea Technologies S.A. in?
Mauna Kea Technologies S.A. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is MKEAF's market cap?
Mauna Kea Technologies S.A. has a market capitalization of $0.03 billion, making it a small-cap company.
Does MKEAF pay dividends?
No, Mauna Kea Technologies S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCHBRF
Chill Brands Group PLC
$0.05
Mkt Cap: $0.0B
CQCQ
MakingORG, Inc.
$0.75
Mkt Cap: $0.0B
DIZTF
Dignitana AB (publ)
$0.22
Mkt Cap: $0.0B
GENH
Generation Hemp, Inc.
$0.22
Mkt Cap: $0.0B
HDSLF
HS GovTech Solutions Inc.
$0.39
Mkt Cap: $0.0B
IBXNF
IBEX Technologies Inc.
$1.00
Mkt Cap: $0.0B
IGXT
IntelGenx Technologies Corp.
$0.17
Mkt Cap: $0.0B
IMMPF
ImmuPharma plc
$0.09
Mkt Cap: $0.0B
KBBTF
Kubota Pharmaceutical Holdings Co., Ltd.
$0.96
Mkt Cap: $0.0B
RTNXF
Renalytix Plc
$0.08
Mkt Cap: $0.0B
Explore stocks similar to MKEAF for comparison